PROFOUND MEDICAL CORP. Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
PROFOUND MEDICAL CORP. (PROF) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of -$20.83 million for the 12-month period ending 2023-12-31, per its 40-F filed 2024-03-07.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2024-03-07
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|
| 2023-12-31 | -$20.83M 40-F · filed 2024-03-07 |
| 2022-12-31 | -$18.77M 40-F · filed 2024-03-07 |
| 2021-12-31 | -$17.00M 40-F · filed 2023-03-07 |
| 2020-12-31 | $66.51M 40-F · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |